{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:08:23Z","timestamp":1790633303518,"version":"4.1.0"},"reference-count":67,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"South African National Research Foundation"},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["90729"],"award-info":[{"award-number":["90729"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"HHS | NIH | NIH Clinical Center","doi-asserted-by":"publisher","award":["NICHD-069169-01"],"award-info":[{"award-number":["NICHD-069169-01"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"HHS | NIH | NIH Clinical Center","doi-asserted-by":"publisher","award":["UM1 AI068634"],"award-info":[{"award-number":["UM1 AI068634"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"HHS | NIH | NIH Clinical Center","doi-asserted-by":"publisher","award":["UM1 AI068636"],"award-info":[{"award-number":["UM1 AI068636"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"HHS | NIH | NIH Clinical Center","doi-asserted-by":"publisher","award":["UM1 AI106701"],"award-info":[{"award-number":["UM1 AI106701"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"HHS | NIH | NIH Clinical Center","doi-asserted-by":"publisher","award":["U01 AI068632"],"award-info":[{"award-number":["U01 AI068632"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"HHS | NIH | NIH Clinical Center","doi-asserted-by":"publisher","award":["AI68632"],"award-info":[{"award-number":["AI68632"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Lopinavir-ritonavir forms the backbone of current first-line antiretroviral regimens in young HIV-infected children. As multidrug-resistant (MDR) tuberculosis (TB) frequently occurs in young children in high-burden TB settings, it is important to identify potential interactions between MDR-TB treatment and lopinavir-ritonavir. We describe the pharmacokinetics of and potential drug-drug interactions between lopinavir-ritonavir and drugs routinely used for MDR-TB treatment in HIV-infected children. A combined population pharmacokinetic model was developed to jointly describe the pharmacokinetics of lopinavir and ritonavir in 32 HIV-infected children (16 with MDR-TB receiving treatment with combinations of high-dose isoniazid, pyrazinamide, ethambutol, ethionamide, terizidone, a fluoroquinolone, and amikacin and 16 without TB) who were established on a lopinavir-ritonavir-containing antiretroviral regimen. One-compartment models with first-order absorption and elimination for both lopinavir and ritonavir were combined into an integrated model. The dynamic inhibitory effect of the ritonavir concentration on lopinavir clearance was described using a maximum inhibition model. Even after adjustment for the effect of body weight with allometric scaling, a large variability in lopinavir and ritonavir exposure, together with strong correlations between the pharmacokinetic parameters of lopinavir and ritonavir, was detected. MDR-TB treatment did not have a significant effect on the bioavailability, clearance, or absorption rate constants of lopinavir or ritonavir. Most children (81% of children with MDR-TB, 88% of controls) achieved therapeutic lopinavir trough concentrations (&gt;1 mg\/liter). The coadministration of lopinavir-ritonavir with drugs routinely used for the treatment of MDR-TB was found to have no significant effect on the key pharmacokinetic parameters of lopinavir or ritonavir. These findings should be considered in the context of the large interpatient variability found in the present study and the study's modest sample size.<\/jats:p>","DOI":"10.1128\/aac.00420-17","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T11:55:26Z","timestamp":1510574126000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis"],"prefix":"10.1128","volume":"62","author":[{"given":"Louvina E.","family":"van der Laan","sequence":"first","affiliation":[{"name":"Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Garcia-Prats","sequence":"additional","affiliation":[{"name":"Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Simon","family":"Schaaf","sequence":"additional","affiliation":[{"name":"Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjokosela","family":"Tikiso","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"de Kock","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Winckler","sequence":"additional","affiliation":[{"name":"Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Norman","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McIlleron","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Denti","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke C.","family":"Hesseling","sequence":"additional","affiliation":[{"name":"Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","volume-title":"Treatment of children living with HIV","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. 2013. Treatment of children living with HIV. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/hiv\/topics\/paediatric\/en\/."},{"key":"e_1_3_3_3_2","volume-title":"Tuberculosis","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. 2015. Tuberculosis. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/518655"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30132-3"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60195-1"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-28"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir772"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0795"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203900"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0679"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2011.11.001"},{"key":"e_1_3_3_13_2","volume-title":"Treatment guidelines for drug-resistant tuberculosis","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. Treatment guidelines for drug-resistant tuberculosis. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/10665\/250125\/1\/9789241549639-eng.pdf?ua=1."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0257-9"},{"key":"e_1_3_3_15_2","first-page":"1355","article-title":"Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis","volume":"13","author":"Schaaf HS","year":"2009","unstructured":"Schaaf HS, Victor TC, Venter A, Brittle W, Jordaan AM, Hesseling AC, Marais BJ, Van Helden PD, Donald PR. 2009. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis. Int J Tuberc Lung Dis 13:1355\u20131359.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01300-12"},{"key":"e_1_3_3_17_2","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_3_18_2","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais BJ","year":"2004","unstructured":"Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, Enarson DA, Donald PR, Beyers N. 2004. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 8:392\u2013402.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-010-0847-9"},{"key":"e_1_3_3_20_2","unstructured":"Reference deleted."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12101"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.13"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.100"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22457"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305020-00023"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31827fd47e"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-9792(08)70016-7"},{"key":"e_1_3_3_28_2","first-page":"169","article-title":"The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol","volume":"50","author":"Lehmann J","year":"1969","unstructured":"Lehmann J. 1969. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol. Scand J Respir Dis 50:169.","journal-title":"Scand J Respir Dis"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg248"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0090-9556(24)15179-3","article-title":"Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes","volume":"28","author":"Wynalda MA","year":"2000","unstructured":"Wynalda MA, Hauer MJ, Wienkers LC. 2000. Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes. Drug Metab Dispos 28:1014\u20131017.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_3_31_2","volume-title":"Second-line antituberculosis drugs in children: a commissioned review for the World Health Organization 19th Expert Committee on the Selection and Use of Essential Medicines","author":"Garcia-Prats Donald PR","year":"2013","unstructured":"Garcia-Prats Donald PR, Hesseling AC, Schaaf HSAJ. 2013. Second-line antituberculosis drugs in children: a commissioned review for the World Health Organization 19th Expert Committee on the Selection and Use of Essential Medicines. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/selection_medicines\/committees\/expert\/19\/applications\/TB_624_C_R.pdf."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr444"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2008.09.017"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.2.382-392.2001"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.15.0044"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000109769"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00001913"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01253-08"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000298"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3016"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00943-05"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.218"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000603"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.11.4328-4331.2004"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03926.x"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.5.898"},{"key":"e_1_3_3_47_2","first-page":"165","article-title":"Protease inhibitor plasma concentrations in HIV antiretroviral therapy","volume":"55","author":"Justesen US","year":"2008","unstructured":"Justesen US. 2008. Protease inhibitor plasma concentrations in HIV antiretroviral therapy. Dan Med Bull 55:165\u2013185.","journal-title":"Dan Med Bull"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050708"},{"key":"e_1_3_3_49_2","first-page":"19","article-title":"Significantly reduced food effect and pharmacokinetic variability with a novel lopinavir-ritonavir tablet formulation","volume":"35","author":"Awni W","year":"2005","unstructured":"Awni W, Chiu YL, Zhu T, Braun N, Klein C, Heuser R, Breitenbach J, Morris J, Doan T, Brun S. 2005. Significantly reduced food effect and pharmacokinetic variability with a novel lopinavir-ritonavir tablet formulation. Age 35:19\u201355. http:\/\/www.medadvocates.org\/resources\/conferences\/3rd%20_ias\/3rdiasawni.pdf.","journal-title":"Age"},{"key":"e_1_3_3_50_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7883\/yoken.JJID.2008.202","article-title":"Serum zinc and albumin levels in pulmonary tuberculosis patients with and without HIV","volume":"61","author":"Ramakrishnan K","year":"2008","unstructured":"Ramakrishnan K, Shenbagarathai R, Kavitha K, Uma A, Balasubramaniam R, Thirumalaikolundusubramanian P. 2008. Serum zinc and albumin levels in pulmonary tuberculosis patients with and without HIV. Jpn J Infect Dis 61:202\u2013204.","journal-title":"Jpn J Infect Dis"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1086\/528860"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318232b057"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.986-990.2003"},{"key":"e_1_3_3_54_2","volume-title":"National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults","author":"Department of Health of the Republic of South Africa","year":"2015","unstructured":"Department of Health of the Republic of South Africa. 2015. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. Department of Health of the Republic of South Africa, Pretoria, South Africa."},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csda.2004.07.002"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-007-9066-0"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200847100-00005"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012299115260"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.48.113006.094708"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0277-z"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-016-2020-3"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.24.25"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23574"},{"key":"e_1_3_3_64_2","volume-title":"Moderate malnutrition","author":"World Health Organization","unstructured":"World Health Organization. Moderate malnutrition. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/nutrition\/topics\/moderate_malnutrition\/en\/."},{"key":"e_1_3_3_65_2","volume-title":"A tutorial on visual predictive checks","author":"Karlsson MO","year":"2008","unstructured":"Karlsson MO, Holford N. 2008. A tutorial on visual predictive checks. Annu Meet Population Approach Group in Europe, Marseille, France."},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011030827847"},{"key":"e_1_3_3_67_2","volume-title":"NONMEM user's guides 1989-2009","author":"Beal S","year":"2009","unstructured":"Beal S, Sheiner L, Boeckmann A, Bauer R. 2009. NONMEM user's guides 1989-2009. Icon Development Solutions, Ellicott City, MD."},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2003.11.003"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00420-17","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00420-17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T20:25:37Z","timestamp":1750969537000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00420-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1128\/AAC.00420-17"],"URL":"https:\/\/doi.org\/10.1128\/aac.00420-17","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732115250.793540735","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"2017-02-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00420-17"}}